A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. [electronic resource]
Producer: 20140220Description: 5169-82 p. digitalISSN:- 1538-7445
- Actin Cytoskeleton -- metabolism
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Cell Differentiation -- drug effects
- Cell Line
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Survival -- drug effects
- Fibroblasts -- drug effects
- Humans
- Melanoma -- drug therapy
- Mice
- NIH 3T3 Cells
- Neoplasms -- drug therapy
- Neuroblastoma -- drug therapy
- Tropomyosin -- antagonists & inhibitors
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.